PMID- 18849489 OWN - NLM STAT- MEDLINE DCOM- 20090127 LR - 20210206 IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 113 IP - 2 DP - 2009 Jan 8 TI - Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. PG - 347-57 LID - 10.1182/blood-2008-02-137745 [doi] AB - By presenting antigenic peptides on the cell surface, human leukocyte antigen (HLA) class I molecules are critical for immune defense. Their surface density determines, to a large extent, the level of CD8(+) T cell-dependent immune reactions; their loss is a major mechanism of immune escape. Therefore, powerful processes should regulate their surface expression. Here we document the mechanisms used by CD99 to mediate HLA class I modulation. Up-regulation of HLA class I by IFN-gamma requires CD99. In the trans Golgi network (TGN), and up to the cell surface, CD99 and HLA class I are physically associated via their transmembrane domain. CD99 also binds p230/golgin-245, a coiled-coil protein that recycles between the cytosol and buds/vesicles of the TGN and which plays a fundamental role in trafficking transport vesicles. p230/golgin-245 is anchored within TGN membranes via its Golgin-97, RanBP1, IMh1p, P230 (GRIP) domain and the overexpression of which leads to surface and intracellular down-modulation of HLA class I molecules. FAU - Bremond, Aurore AU - Bremond A AD - Inserm UMR 576, Nice, France. FAU - Meynet, Ophelie AU - Meynet O FAU - Mahiddine, Karim AU - Mahiddine K FAU - Coito, Sylvie AU - Coito S FAU - Tichet, Melanie AU - Tichet M FAU - Scotlandi, Katia AU - Scotlandi K FAU - Breittmayer, Jean-Philippe AU - Breittmayer JP FAU - Gounon, Pierre AU - Gounon P FAU - Gleeson, Paul A AU - Gleeson PA FAU - Bernard, Alain AU - Bernard A FAU - Bernard, Ghislaine AU - Bernard G LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20081010 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (12E7 Antigen) RN - 0 (Antigens, CD) RN - 0 (Antiviral Agents) RN - 0 (Autoantigens) RN - 0 (CD99 protein, human) RN - 0 (Cell Adhesion Molecules) RN - 0 (GOLGA4 protein, human) RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Membrane Proteins) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - 12E7 Antigen MH - Antigens, CD/*immunology/metabolism MH - Antiviral Agents/immunology/pharmacology MH - Autoantigens/*immunology/metabolism MH - CD8-Positive T-Lymphocytes/*immunology/metabolism MH - Cell Adhesion Molecules/*immunology/metabolism MH - Cytosol/immunology/metabolism MH - Golgi Apparatus/*immunology/metabolism MH - HLA Antigens/biosynthesis/immunology MH - Histocompatibility Antigens Class I/biosynthesis/*immunology MH - Humans MH - Immunity, Cellular/physiology MH - Interferon-gamma/immunology/pharmacology MH - Jurkat Cells MH - Membrane Proteins/*immunology/metabolism MH - Protein Structure, Tertiary/physiology MH - Protein Transport/drug effects/immunology MH - Transport Vesicles/immunology/metabolism MH - Up-Regulation/drug effects/*immunology EDAT- 2008/10/14 09:00 MHDA- 2009/01/28 09:00 CRDT- 2008/10/14 09:00 PHST- 2008/10/14 09:00 [pubmed] PHST- 2009/01/28 09:00 [medline] PHST- 2008/10/14 09:00 [entrez] AID - S0006-4971(20)37883-6 [pii] AID - 10.1182/blood-2008-02-137745 [doi] PST - ppublish SO - Blood. 2009 Jan 8;113(2):347-57. doi: 10.1182/blood-2008-02-137745. Epub 2008 Oct 10.